All Business articles – Page 8
View all stories with this category.
-
OpinionWill Novartis's data manipulation damage relations with regulators?
Trust between the two has been compromised
-
News
Data manipulation casts shadows on Novartis gene therapy
Manufacturing problems with other new medicines highlight difficulty of developing advanced treatments
-
Opinion
Has x-ray had its day?
Will the giant of structure determination be toppled by blasts from electron beams?
-
Opinion
Are new drugs better than existing ones?
Should companies be made to change the way they run clinical trials?
-
Business
Enhancing solvents' sustainability
Increased recycling and replacing toxic solvents with greener alternatives will reduce environmental impact
-
Business
Pfizer’s Upjohn to merge with Mylan
Deal combines Pfizer’s off-patent drug portfolio with Mylan’s generics
-
Business
US ditches chlorpyrifos ban for food crops
Environmental Protection Agency says evidence of harm from food residues is insufficient
-
Business
HexagonFab cracks nanomanufacturing for pocket diagnostics
HexagonFab’s founders say their graphene-based sensors are set to become the lab tests that don’t need a physical lab
-
Business
US judges slash damages in glyphosate cancer lawsuits
While upholding rulings linking the herbicide to cancer, judges have cut Bayer-Monsanto’s fines from billions to tens of millions of dollars
-
Business
Curbing industry’s carbon emissions
Replacing fossil-fuelled furnaces with renewable electrical heating and cutting carbon from some heavy industries could make a serious dent in climate targets
-
Opinion
The silent rise of the robots
Mechanical helpers have been creeping into our labs for decades
-
Business
Profile: Oxford nanoSystems’ heat transfer coatings
Nanospiked coatings drastically increase heat exchangers’ efficiency and can be applied after manufacturing
-
Business
BASF to axe 6000 jobs worldwide
5% cut to global staff part of a drastic restructuring to simplify corporate structure
-
Opinion
Get with the quantum program
Now is the time for industry to engage with the emerging world of quantum computers
-
Opinion
Is this a golden age of new drug classes?
A host of new treatment modes are hitting the clinic and the market
-
Business
Industry adopts quantum computing, qubit by qubit
Companies looking to solve complex chemistry problems are among early adopters of quantum technology
-
Business
China makes slow progress on safety
Government policy drive continues, as self-regulation also grows
-
Business
US finalises guidance on biosimilars
Regulator clarifies requirements for allowing substitution between products
-
Business
Industry criticises proposed US asbestos ban
Outright ban would compromise chlorine supply and public health, claims trade body
-
Opinion
Is Bayer regretting its Monsanto takeover?
Large damages in Roundup litigation have got investors questioning the move
